Taro Pharma and NextWave to co-promote head lice drug - Trading Markets (press release)
Friday, August 1st, 2008Taro Pharma and NextWave to co-promote head lice drug Trading Markets (press release), CA - Aug 1, 2008 Ovide is a prescription drug approved by the FDA for the treatment of head lice. In August 2008, NextWave's pediatric specialty sales force will begin ... |